Thursday, April 24, 2025 | 07:08 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

News digest: DPCO amendment, Mallya declared fugitive offender, and more

From Christian Michel reciving kickbacks in defence deals to Pratt and Whitney's A320 engines trouble, BS brings you top stories to keep up with the latest news

News digest: DPCO amendment, Mallya declared fugitive offender, and more
Premium

BS Web Team New Delhi
DPCO amendment may benefit MNC device makers by allowing price control

Recent amendments to the Drug Prices Control Order (DPCO), 2013, have fuelled concerns that the authorities might find it difficult to keep the prices of essential medical devices in check as multinational firms would now be able to use patent protection to exempt such equipment from price control for five years.

According to a government notification, new drugs patented under the Indian Patent Act will be exempted from price control for five years from the date of the commencement of their commercial marketing by the manufacturer in the country.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in